Table 5.
Tumor response | SG1 n = 60 |
SG2 n = 67 |
p-value |
---|---|---|---|
Pathologic tumor response | 0.0217 | ||
pCR | 11(18%) | 17(25%) | |
pPR | 43 (72%) | 50 (75%) | |
pSD | 6 (10%) | 0 (0%) | |
| |||
Pathologic T stage | 0.0008 | ||
T0 | 14 (23%) | 21 (31%) | |
Tis | 2 (3%) | 1 (2%) | |
T1 | 3 (5%) | 4 (6%) | |
T2 | 15 (25%) | 19 (28%) | |
T3 | 26 (43%) | 19 (28%) | |
T4 | 0 (0%) | 2 (3%) | |
| |||
Pathologic N stage | 0.6606 | ||
N0 | 45 (75%) | 50 (75%) | |
N1 | 7 (12%) | 10 (15%) | |
N2 | 8 (13%) | 7 (10%) |
Per-Protocol Set as described in Figure 2. Abbreviations: pCR - Pathologic complete response; pPR - Pathologic partial response; pSD - Stable disease.